baber/WOPTO huggingface dataset:
Patent AU-2012256498-A1 (AU)
Title: Evaporator system
Inventor: VAN GILS GERARDUS ADRIANUS JOSEPHUS
IPC: B01D1/28
Filed: 2012-05-14
Abstract: Evaporator system of the mechanical vapor recompression type, which has a housing (1) and evaporator tubes (2) positioned parallel to each other. A product inlet (3) in fluid communication with a distribution element (4) is connected to the evaporator tubes (2), and a secondary channel (5) is formed between the inside surface of the housing (1) and the external surfaces of the evaporator tubes (2). A vapor liquid separator (6) is positioned at a bottom side of the evaporator tubes (2) and the secondary channel (5). A compressor (7) is in fluid communication with a vapor outlet of the vapor liquid separator (6), and a second transport tube (8) is connected to an inlet (9) of the secondary channel (5). Each evaporator tube (2) of the plurality of evaporator tubes has an inner diameter (de) of at least 50 mm.
Patent AU-2012268920-A1 (AU)
Title: Rockable biocontainer
Inventor: BARRETT TIMOTHY ALAN
IPC: B01F11/00
Filed: 2012-12-20
Abstract: Biocontainers 100, as well as methods and platforms 500 for rocking the biocontainers 100, are disclosed.
Patent AU-2012293312-A1 (AU)
Title: A novel method for peroral delivery of insulin and its analogues for therapeutic usage
Inventor: KOTESWARA RAO KOLLIPARA
IPC: A61K47/00
Filed: 2012-08-07
Abstract: A method for treating type 1 and type 2 diabetes by administering an oral pharmaceutical formulation which comprises of insulin or its analogues amalgamated with suitable encapsulating agents and pharmaceutical excipients. The encapsulated pharmaceutical oral formulation protects insulin or its analogues from harsh milieu of the gastrointestinal tract and facilitates efficient delivery of insulin at targeted sites with sustained hypoglycemic activity.
Patent AU-2012301715-A1 (AU)
Title: Pegylated liposomes for delivery of immunogen-encoding RNA
Inventor: GEALL ANDREW
IPC: A61K39/39
Filed: 2012-08-31
Abstract: Nucleic acid immunisation is achieved by delivering RNA encapsulated within a PEGylated liposome. The RNA encodes an immunogen of interest. The PEG has an average molecular mass above 3kDa but less than 11kDa. Thus the invention provides a liposome having a lipid bilayer encapsulating an aqueous core, wherein: (i) the lipid bilayer comprises at least one lipid which includes a polyethylene glycol moiety, such that polyethylene glycol is present on the liposome's exterior, wherein the average molecular mass of the polyethylene glycol is above 3kDa but less than 11kDa; and (ii) the aqueous core includes a RNA which encodes an immunogen. These liposomes are suitable for in vivo delivery of the RNA to a vertebrate cell and so they are useful as components in pharmaceutical compositions for immunising subjects against various diseases.
Patent AU-2012319199-A1 (AU)
Title: Method and apparatus for detecting lameness in livestock
Inventor: AXELSSON THOMAS
IPC: A61B5/11
Filed: 2012-10-05
Abstract: A device and method is proposed for detecting lameness in a standing animal that comprises at least one optical imaging device (20) and a processing arrangement (30) with the optical imaging device. The optical imaging device (20) is arranged in a position to capture at least one image showing the lower portions of at least one leg of an animal (100) and to forward the image to the processing arrangement (30), which, in turn, is configured to analyse the image to determine a condition of lameness when said at least one leg is held in a raised position on or above ground level. The system is particularly suited to detecting lameness in dairy animals and can be integrated in a milking or feeding stall or with an automatic or semi-automatic milking system.
Patent AU-2012333121-A1 (AU)
Title: Systems and methods to secure user identification
Inventor: CARLSON MARK
IPC: H04L9/32
Filed: 2012-09-21
Abstract: In one aspect, a computing apparatus is configured to verify a digital signature applied on a set of data received from a user device, including an user ID assigned by a partner system to uniquely identify a user of the user device among customers of the partner system, and a user device identifier identifying the user device. The digital signature is generated via applying a cryptographic one-way hash function on a combination of the set of data and a secret, shared between the computing apparatus and the partner system via a secure communication channel separate from a channel used to receive the set of data.
Patent AU-2012362364-A1 (AU)
Title: Methods of isolating (4-chloro-2-fluoro-3-substituted-phenyl) boronates and methods of using the same
Inventor: OPPENHEIMER JOSSIAN
IPC: C01B32/50
Filed: 2012-12-28
Abstract: Methods of isolating a 4-chloro-2-fluoro-3-substituted-phenylboronate include adding carbon dioxide gas or carbon dioxide solid (dry ice) to a solution comprising a 4-chloro-2-fluoro-3-substituted-phenylboronate, an inert organic solvent, and at least one lithium salt to react the at least one lithium salt with the carbon dioxide gas or carbon dioxide solid (dry ice) and form a mixture comprising the 4-chloro-2-fluoro-3- substituted-phenylboronate, the inert organic solvent, and a precipitated solid. The precipitated solid may be removed from the mixture. Methods of using 4-chloro-2- fluoro-3-substituted-phenylboronates to produce methyl-4-amino-3-chloro-6-(4-chloro- 2-fluoro-3-substituted-phenyl)pyridine-2-carboxylates are also disclosed. A 4-chloro-2-fluoro-3-substituted-phenylboronate produced by one of the methods of isolating a 4-chloro-2-fluoro-3-substituted-phenylboronate is also disclosed, wherein the 4-chloro-2-fluoro-3-substituted-phenylboronate may be obtained at a yield of greater than or equal to about 90%.
Patent AU-2012372783-A1 (AU)
Title: System and method for treating bone fractures
Inventor: MEDOFF ROBERT
IPC: A61B17/56
Filed: 2012-12-19
Abstract: A system and method for treating a fracture of a bone that produces first and second bone parts separated by a fracture line. A first implant has a first body. A second implant has a second body, A first elongate component can be directed through the bone to cooperate with each of the first and second bodies so that the first and second bodies and first component together act to maintain the first and second bone parts in a desired set relationship. The first component has a lengthwise axis and cooperates with the first body so that the operatively positioned first component is stabilized by the first body in a direction that is transverse to the lengthwise axis of the first component. The first component cooperates with the second body so that the first component is stabilized by the operatively positioned second body.
Patent AU-2012396134-A1 (AU)
Title: Microwave vacuum-drying of organic materials
Inventor: DURANCE TIMOTHY D
IPC: F26B23/00
Filed: 2012-12-07
Abstract: An apparatus and method for microwave vacuum-drying of organic materials such as food products. The dehydration apparatus (20) has a vacuum chamber (24) with an input module (28) at one end and a discharge module (32) at the other. The vacuum chamber has access doors (80) spaced between the input end (30) and the discharge end (34) which provide operator and maintenance access. Microwave generators (86) are mounted on each access door and arranged to radiate through a microwave chamber and microwave-transparent window on the access door into the vacuum chamber. A pair of rollers (60) in the vacuum chamber rotates the container of organic material (1 12) about a horizontal axis, and a chain drive (64) pulls the containers along the rollers through the vacuum chamber.
Patent WO-2013155561-A1 (WO)
Title: A system and method for enabling a referral of a product
Inventor: WOOLF AARON
IPC: G06Q30/02
Filed: 2013-04-17
Abstract: A system for enabling a referral of a product, comprising: a retriever for retrieving from a database a product identifier; a generator for generating product referral data with respect to an external system using the retrieved product identifier, wherein the generated product referral data is retrievable by a first device in communication with the external system, the product referral data once retrieved being for addition to an external database in communication with the external system, by accessing the external system using a nominated user identifier of a user, and the product referral data once added to the external database is retrievable by a second device in communication with the external system, the product referral data once retrieved by the second device being for generation of user identification data corresponding to the nominated user identifier; and a receiver for receiving the user identification data and making an award to the user.
Patent WO-2013188923-A1 (WO)
Title: A heating torch
Inventor: BUDEN MARTIN GEORGE
IPC: F23D14/58
Filed: 2013-06-21
Abstract: A heating torch (10) for burning a mixture of fuel and air. The heating torch (10) includes a fuel inlet port (12) for supplying fuel from a fuel source to an air entrainment chamber (14). The air entrainment chamber (14) includes at least one air inlet (22) for supplying air from the atmosphere to the air entrainment chamber (14). The air entrainment chamber 14 includes an outlet (26) for discharging from the air entrainment chamber (14) a mixture of fuel and air in a flow path extending from the outlet (26). The heating torch (10) also includes a combustion chamber (28) provided in the flow path A and spaced from the outlet (26). The combustion chamber (28) has an open end (30) facing in a generally downstream direction away from the outlet (26). The combustion chamber (28) includes at least one side opening (36) extending along a side of the combustion chamber (28).
Patent AU-2013206768-A1 (AU)
Title: Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methods
Inventor: GRAUS PORTA DIANA
IPC: G01N33/68
Filed: 2013-07-10
Abstract: The present invention relates generally to methods of in vitro diagnostics, in particular the use of a compound selected from the group consisting of fibroblast growth factor 23 (FGF23), inorganic phosphorus (P), the product of inorganic phosphorus and total calcium (P x tCa), osteopontin (OPN) and parathyroid hormone (PTH) as biomarker. Said biomarkers can be used to monitor the modulation of fibroblast growth factor receptor (FGFR) kinase activity, in particular its inhibition, and/or the occurrence of secondary effects of FGFR inhibition. The invention further provides methods and kits relating to these uses.
Patent AU-2013207652-A1 (AU)
Title: Balancer device for parallel twin cylinder internal combustion engine
Inventor: IIDA AKIHIRO
IPC: F16F15/26
Filed: 2013-07-22
Abstract: BALANCER DEVICE FOR PARALLEL TWIN CYLINDER INTERNAL COMBUSTION ENGINE A device is provided for reducing first cylinder vibratory force (Fl) and second cylinder vibratory force (F2) which are generated when a crankshaft is rotated, in a parallel twin cylinder internal combustion engine in which a crankshaft is provided with a first crankpin and a second crankpin at a predetermined phase angle and a cylinder block is formed with a first cylinder and a second cylinder. In the device, a straight line for bisecting an angle formed between the first cylinder vibratory force (Fl) and the second cylinder vibratory force (F2) is defined as an angle bisector, force with the first cylinder vibratory force (Fl) and the second cylinder vibratory force (F2) resolved in a direction parallel to the angle bisector is defined as an inertial force component, force with the first cylinder vibratory force (Fl) and the second cylinder vibratory force (F2) resolved in a direction parallel to a plane perpendicular to the angle bisector is defined as a couple component, an inertial force balancer is provided for generating force facing the inertial force component, and a couple balancer is provided for generating force facing the couple component. oU-0 'N. x U)'m 'I MlNJ C) U
Patent AU-2013214776-A1 (AU)
Title: Adenoviruses expressing heterologous tumor-associated antigens
Inventor: FUEYO-MARGARETO JUAN
IPC: C12N15/861
Filed: 2013-02-01
Abstract: The present invention is directed to adenoviruses for use in cancer therapy which comprise one or more heterologous nucleic acid sequences encoding a tumor antigen, whereby the adenovirus expresses the tumor antigen(s) on its surface.
Patent AU-2013215749-A1 (AU)
Title: Method and apparatus for channel access via null data packet frame in wireless LAN system
Inventor: SEOK YONGHO
IPC: H04W74/08
Filed: 2013-02-05
Abstract: The present invention relates to a wireless communication system, and more specifically to a method and an apparatus for channel access via a null data packet frame in a wireless LAN system. A method for channel access from a station (STA) in a wireless communication system according to one embodiment of the present invention comprises the steps of: receiving, from an access point (AP), configuration information for one or more slots for channel access; receiving a first frame, from the AP, from a particular slot from among the one or more slots; and starting channel access after receiving the first frame, wherein the first frame can be a null data packet (NDP) frame.
Patent AU-2013217676-A1 (AU)
Title: Method and apparatus for performing a geometric transformation on objects in an object-oriented environment using a multiple-transaction technique
Inventor: HEROLD STEVEN D
IPC: G06F17/30
Filed: 2013-01-24
Abstract: A large number of objects, such as objects representing beams and columns in an object- oriented enterprise engineering system, may be geometrically transformed in a model database by dividing the objects according to criteria into a number of ordered partitions and transforming the objects in each partition as an atomic operation. Objects that are to be transformed are organized into the ordered partitions, and the partitions are transformed in sequential order, such that all predecessors of a given object are transformed before, or in the same operation as, the given object. If a large transformation operation abnormally terminates before all the small transformation operations have been completed, the model database is, nevertheless, left in a consistent state. The transformation operation may be resumed from the point of interruption. Furthermore, the number of objects that may be transformed is not constrained by the amount of memory available in the system.
Patent AU-2013225681-A1 (AU)
Title: Porous structure with independently controlled surface patterns
Inventor: CHAREST JOSEPH L
IPC: C12M1/12
Filed: 2013-03-04
Abstract: Disclosed herein are systems and methods for manufacturing and using a cell culture support device. The device includes a plurality of polymer layers, each with at least one flow chamber defined therethrough. The device also includes a cross channel interface between the channels of different polymer layers. The cross channel interface includes a plurality of pores and a topographical pattern that is selected independent of the plurality of pores. Furthermore, the formation of the topographical pattern preservers the pores.
Patent AU-2013234422-A1 (AU)
Title: Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
Inventor: SCOTT JACK D
IPC: A61K31/54
Filed: 2013-09-30
Abstract: IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE Abstract In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I) and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R', R 2, R', R4, R 5, R9, ring A, ring B3, mn, n, p, -L1-,L2-, and L-3 is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to $-amyloid (A$) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (A$) protein, including Alzheimers disease, are also disclosed.
Patent AU-2013235368-A1 (AU)
Title: Method and system for quick square roof reporting
Inventor: THORNBERRY CHRIS T
IPC: G06Q50/10
Filed: 2013-03-18
Abstract: A set of instructions stored on one or more computer readable medium for running on one or more computer systems is described herein. The set of instructions generally may include instructions for identifying a geographic location of a roof, instructions for determining contact information of one or more contractors within a region of interest of the geographic location of the roof, instructions for determining a footprint of the roof, instructions for determining predominant pitch of the roof, and/or instructions for determining an estimated roofing area based on the predominant pitch and the footprint of the roof.
Patent AU-2013239018-A1 (AU)
Title: Method for producing jet fuel composition and jet fuel composition
Inventor: NIITSUMA TAKUYA
IPC: C10L1/04
Filed: 2013-01-15
Abstract: The objective of the present invention is to provide a method for producing a jet fuel composition and a fuel composition, the method being capable of producing a jet fuel composition with excellent quality at high yield even when a jet fuel base material derived from an FT synthetic oil is used. In order to achieve this objective, the present invention is characterized by mixing a specific Fischer-Tropsch (FT) synthetic jet fuel base material and a specific petroleum jet fuel base material so that the proportion of the FT synthetic jet fuel base material is within the range of 20 to 80 volume%.
Patent AU-2013249251-A1 (AU)
Title: Method and apparatus for an intuitive customer experience
Inventor: KANNAN PALLIPURAM V
IPC: G06Q10/00
Filed: 2013-04-18
Abstract: Improvement of customer experiences during online commerce is accomplished by providing unique experiences to customers as a result of anticipating customer needs, simplifying customer engagement based on predicted customer intent, and updating system knowledge about customers with information gathered from new customer interactions. In this way, the customer experience is improved.
Patent AU-2013251194-A1 (AU)
Title: Drive pin assembly
Inventor: RUIZ STEPHEN JOHN
IPC: F16B19/00
Filed: 2013-10-29
Abstract: [371 Provided are, among other things, systems, apparatuses, components and methods related to drive pin assemblies. One such assembly includes: a first pin component and a second pin component, each having an engagement end that opens to an interior space and has an angled surface that extends for at least a portion of the width and a portion of the length of such first pin component; and a tightening mechanism at least partially disposed within the interior spaces of the first pin component and the second pin component, for drawing the first pin component and the second pin component closer together, where the angled surface of the first pin component matches the angled surface of the second pin component such that the first pin component and the second pin component slide both vertically and laterally along each other when drawn together.
Patent AU-2013262775-A1 (AU)
Title: Enclosure for use of prime mover in a hazardous environment
Inventor: KINCAID JESSE
IPC: H02K5/10
Filed: 2013-05-16
Abstract: A prime mover assembly is suitable for use in a hazardous environment. The prime mover assembly includes a hazardous rated enclosure, a non-hazardous rated prime mover disposed in the enclosure, and a gland assembly extending through the enclosure in communication with the prime mover. The gland assembly provides power and instrumentation through the enclosure to the prime mover.
Patent AU-2013263346-A1 (AU)
Title: Methods and compositions for treating amyloid deposits
Inventor: DAVIDSON BEVERLY L
IPC: C12N15/861
Filed: 2013-03-14
Abstract: The present disclosure provides methods of delivering a protective ApoE isoform to the central nervous system of a mammal, comprising administering to the cerebrospinal fluid (CSF) of the mammal an rAAV particle comprising an AAV capsid protein and a vector comprising a nucleic acid encoding the protective ApoE isoform inserted between a pair of AAV inverted terminal repeats in a manner effective to infect ependymal cells in the non-rodent mammal such that the ependymal cells secrete the ApoE into the CSF of the mammal.
Patent AU-2013281125-A1 (AU)
Title: Method of controlling scale in steam generating systems
Inventor: MESKERS JR DONALD A
IPC: C02F5/10
Filed: 2013-05-29
Abstract: Water soluble or water dispersible terpolymers are employed in high pressure steam generating systems to control deposit formation and contaminant transport in the aqueous medium in such systems. The terpolymer may comprise repeat units formed from acrylic acid, allylalkoxylated ethers, and allylhydroxylated alkyl ether.
Patent AU-2013287390-A1 (AU)
Title: Portable terminal using touch pen and handwriting input method using the same
Inventor: KIM HWA-KYUNG
IPC: G06F3/14
Filed: 2013-07-15
Abstract: An apparatus and method for a portable terminal using a touch pen and a handwriting input method using the same are provided. In the apparatus, upon receipt of a handwriting image in an input field provided by an executed application through the touch pen, the received handwriting image is converted to text, the text is inserted in the input field, and the input field with the text is displayed.
Patent AU-2013295288-A1 (AU)
Title: Spring core having a fully active spring and method of manufacturing the same
Inventor: JORGENSEN MORTEN
IPC: A47C23/04
Filed: 2013-07-09
Abstract: A pocket spring core for a bedding or seating cushion comprises an array of pocket springs. The array of pocket springs comprises fully active springs (10) respectively enclosed in an associated pocket (35) of fabric. Each fully active spring (10) respectively has a central spiral portion (20) with at least one turn and defining a spring axis (13), an unknotted first end turn (21) defining a first end of the fully active spring (10), and an unknotted second end turn (22) defining an opposing second end of the fully active spring (10). Each fully active spring (10) has a rest shape in which the first end turn (21) and the second end turn (22) have a finite pitch angle, so that the first end turn (21) and the second end turn (22) contribute to a spring force of the fully active spring (10).
Patent AU-2013304949-A1 (AU)
Title: NEP inhibitors for treating diseases characterized by atrial enlargement or remodeling
Inventor: SCHUMACHER CHRISTOPH
IPC: A61K45/06
Filed: 2013-08-22
Abstract: The present invention relates to the NEP inhibitor pro-drug N-(3-carboxy-1-oxopropyl)-(4S)-p-phenylphenylmethyl)-4-amino-(2R)-methylbutanoic acid ethyl ester, or a pharmaceutically acceptable salt thereof; or the NEP inhibitor N-(3-carboxy-1-oxopropyl)-(4S)-p-phenylphenylmethyl)-4-amino-(2R)-methylbutanoic acid, or a pharmaceutically acceptable salt thereof, pro-drug for use in the treatment, prevention or delay of progression of a disease characterized by atrial enlargement and/or remodeling; a method for treatment, prevention or delay of progression of a disease characterized by atrial enlargement and/or remodeling comprising administration of a therapeutically effective amount, or a prophylactically effective amount, of the NEP inhibitor or the NEP inhibitor pro-drug, or a pharmaceutically acceptable salt pro-drug thereof, to a subject, e.g. a human subject, in need of such treatment. The present invention further relates to a pharmaceutical composition or a commercial package comprising the NEP inhibitor or the NEP inhibitor pro-drug, or a pharmaceutically acceptable salt thereof, pro-drug for use in the treatment, prevention or delay of progression of a disease characterized by atrial enlargement and/or remodeling.